An experienced leader in the development of new drug therapies with twenty years of progressive scientific, managerial and executive responsibilities in the field of preclinical drug research, including ADMET and bioanalysis. Lead preclinical research efforts at a major Canadian biopharma company. Responsible for the inception, build-out, and consistent profitability of the drug metabolism unit at one of the world’s top-five contract research organizations. A strong interpersonal, problem-solving style of leadership based on the foundations of trust, respect, integrity, and teamwork.Specialties: Experienced in the design, execution and interpretation of a wide variety of preclinical services used in the BioPharma industry to bring new molecular entities through the drug development process.
Listed skills include Drug Development, Cro, Biopharmaceuticals, Pharmaceutical Industry, and 26 others.